1 Taxanes are antineoplastic drugs which have cardiovascular side eects of unknown mechanism. We investigated their in¯uence on blood viscosity and erythrocyte morphology. 2 Whole blood was incubated in vitro with increasing concentrations of Taxol 1 , Taxotere 1 , paclitaxel (0 ± 100 mM) and the vehicles Cremophor-EL and Tween 80 (0 ± 5% vol) for 1 h at 378C. Plasma and whole blood viscosity (Haematocrit 45%) were measured and erythrocyte morphology was assessed on glutaraldehyde-®xed cells. The same investigations were performed in seven patients before and after a Taxol , respectively, induced a comparable degree of stomatocytosis. This suggests a preferential intercalation of these substances into the inner hemilea¯et of the membrane lipid bilayer. Associated with this shape change a dose-dependent increase in plasma and whole blood viscosity was observed. Neither shape nor viscosity changes were reversible upon removal of the agents. After the infusion of 130 ± 300 mg Taxol 1 in patients a slight shift towards stomatocytosis and an increase in whole blood viscosity at high shear rate from 5.09+0.30 to 5.44+0.38 mPa.s (P50.05) were con®rmed. 4 Commercial taxane drug formulations induce stomatocytosis and increase blood viscosity, which is due to their formulation vehicles. These ®ndings may contribute to the understanding of the cardiovascular side eects of these drugs.
1 Taxanes are antineoplastic drugs which have cardiovascular side eects of unknown mechanism. We investigated their in¯uence on blood viscosity and erythrocyte morphology. 2 Whole blood was incubated in vitro with increasing concentrations of Taxol 1 , Taxotere 1 , paclitaxel (0 ± 100 mM) and the vehicles Cremophor-EL and Tween 80 (0 ± 5% vol) for 1 h at 378C. Plasma and whole blood viscosity (Haematocrit 45%) were measured and erythrocyte morphology was assessed on glutaraldehyde-®xed cells. The same investigations were performed in seven patients before and after a Taxol 1 -infusion. 3 Taxol 1 and Taxotere 1 induced a dose-and time-dependent stomatocytic shape transformation of erythrocytes. Paclitaxel alone had no eect, but the vehicles cremophor-EL and Tween 80, used in Taxol  1 and Taxotere
Introduction
Taxanes are antimicrotubule agents with activity against a broad range of cancers, including ovarian, breast, non-smallcell lung, and head and neck cancers (Crown & O'Leary, 2000; Rowinsky & Donehower, 1995) . A problem encountered with these drugs is their low aqueous solubility. For this reason, paclitaxel (Taxol 1 ) is administered in a mixture of cremophor-EL (a derivative of castor oil and ethylene oxide):ethanol and docetaxel (Taxotere 1 ) in tween 80 (polyoxyethylene sorbitanmonooleate):ethanol (Sparreboom et al., 1998) .
Taxol 1 can cause cardiovascular side eects. Although they are usually transient and asymptomatic, fatal events have been reported (Rowinsky & Donehower, 1995; Arbuck et al., 1993; Rowinsky et al., 1991; Laher & Karp, 1997; Hekmat, 1996; Roth et al., 1993) . The underlying mechanism remains elusive. A Taxol 1 -induced alteration of the plasma membrane composition has been suggested (Hamm-Alvarez et al., 1994) . The formulation vehicle cremophor-EL itself has cardiovascular side eects, e.g. a decrease in cardiac output, mean arterial pressure and organ blood¯ow in a canine model (Bowers et al., 1991) , decreased renal blood¯ow and glomerular ®ltration rate and increased renal vascular resistance in rats (Besarab et al., 1987) . Major hypersensitivity reactions after Taxol 1 -based chemotherapies had been attributed to the propensity of cremophor-EL to release histamine (Rowinsky et al., 1991) . There is only scant knowledge on the in¯uence of cremophor-EL on blood rheology and blood cell morphology. Both decreased and increased plasma viscosity have been reported after the application of cremophor-EL containing anaesthetics (Gramstad & Stovner, 1979; Orr et al., 1982; Gibbs et al., 1984) . Poikilocytosis and rouleaux formation of red cells has recently been observed after the application of Taxol 1 and has been attributed to cremophor-EL (Shimomura et al., 1998) .
Based on these ®ndings, we hypothesized that taxane-based chemotherapies may in¯uence blood rheology, which would oer an explanation for cardiovascular side eects. The present study was designed to test this hypothesis.
Methods

Drugs
Commercial solutions of Taxol 1 paclitaxel (from Taxus brevifolia) were purchased from Sigma (Buchs, Switzerland). A stock solution of paclitaxel (5 mM) was dissolved in methanol containing 0.1% acetic acid (both from Fluka, Buchs, Switzerland), light-protected, and stored at 7208C prior to use. Tween 1 80 (polyoxyethylene sorbitanmonooleate) was from Fluka.
In vitro study
Blood from healthy volunteers was drawn into K 3 -EDTA (ethylene-diaminetetraacetic acid) containing tubes (Becton Dickinson Vacutainer 1 System, Plymouth, U.K.). The haematocrit was determined with an electronic particle counter (Sysmex K-1000, Kobe, Japan). Samples were centrifuged at 1000 6 g for 10 min. Plasma samples were separated, incubated with dierent concentrations of one drug for 60 min in a water bath at 378C and plasma viscosity was measured as described below. For these experiments, autologous plasma was used for dilution of drugs as required. Experiments measuring blood viscosity were prepared as follows: the haematocrit of whole blood was ®rst adjusted to 50% by removing a calculated volume of plasma. Several aliquots were prepared. One part of drug diluted in autologous plasma was added to nine parts of whole blood to yield a ®nal haematocrit of 45% and ®nal drug concentrations of 0, 5, 10, 25, 50, and 100 mM. Blood from one donor was used for two control experiments (addition of autologous plasma only) and experiments with the addition of one drug. When not stated otherwise, the specimens were incubated for 60 min in a water bath at 378C. and 37.6 s 71 was calculated (note: in contrast to whole blood, plasma is a Newtonian¯uid, i.e. its viscosity is shear rateindependent (Chien, 1975) ).
Red blood cell (RBC) morphology
RBCs were ®xed in 1% glutaraldehyde (Fluka) in phosphatebuered saline (mM: PBS: NaCl 131, Na 2 KPO 4 30, D-glucose 11, pH 7.4, mOsm kg 71 300) RBC morphology was quanti®ed on ®xed cells by light microscopy according to the slightly modi®ed nomenclature of Bessis (Bessis, 1972) with the help of a scoring system (Ferrell & Huestis, 1984) : a discocyte obtained a score of zero; echinocytic transformation was classi®ed as: echinocyte I (score: +1; irregularly contoured discocyte with up to ®ve protrusions); echinocyte II (score: +2;¯at cell with multiple spicules); echinocyte III (score: +3; ovoid or spherical erythrocyte with multiple spicules); spheroechinocyte (score:+4; a sphere with multiple short and thin spicules). Stomatocytic transformation was classi®ed as: stomatocyte I (score: 71; cup-shaped erythrocyte (convex-concave erythrocyte)); stomatocyte II (score: 72; RBC with a pronounced, often longitudinal concavity); stomatocyte III (score: 73; RBC with more than one concavity); and spherostomatocyte (score: 74; spherical RBC with an irregular area of pits). For each specimen, 200 RBCs were classi®ed and the morphological index calculated as S scores/200 (Ferrell & Huestis, 1984) . Selected Taxanes and blood rheology M. Mark et alsamples of ®xed RBCs were also prepared for scanning electron microscopy with methods described before (Reinhart et al., 1999) .
Ex vivo study
For ex vivo experiments, seven consecutive patients undergoing chemotherapies which included Taxol 1 were recruited. Their characteristics are shown in Table 1 . They gave their informed consent for the necessary additional blood withdrawal. Ten ml of blood anticoagulated with EDTA was drawn directly before and after the exclusive intravenous administration of Taxol 1 . Samples of plasma and whole blood with an adjusted haematocrit of 45% were prepared. Viscosity and RBC morphology were determined after incubation for 30 min in a water bath at 378C as described above.
Statistical analysis
Results are presented as means+s.d. Paired t-tests (ex vivo study) or one-way analysis of variance (ANOVA) for 
Results
In vitro incubation of whole blood with a haematocrit adjusted to 45% and plasma of healthy volunteers with Taxol 1 for 1 h resulted in a dose-dependent increase of both whole blood viscosity at high (94.5 s
71
) and low (0.945 s 71 ) shear rate as well as plasma viscosity (Figure 1) . At the highest dose examined, yielding a concentration of 100 mM paclitaxel, the increase of whole blood viscosity was 20% at high shear rate and 61% at low shear rate, whereas plasma viscosity increased by 6% as compared to corresponding controls.
In contrast, neither whole blood viscosity nor plasma viscosity changed signi®cantly when blood was incubated with pure paclitaxel at similar concentrations without the formulation vehicle cremophor-EL (Figure 2) . In vitro incubation of whole blood and plasma of healthy volunteers with cremophor-EL for 1 h, however, dose-dependently increased both whole blood viscosity at high and low shear rate as well as plasma viscosity, as shown in Figure 3 . The highest concentration examined (5%) resulted in an increase of whole blood viscosity by 34% at high shear rate and 82% at low shear rate, and plasma viscosity increased by 17% as compared to corresponding controls.
As shown in Figure 4 , in vitro incubation of whole blood and plasma of healthy volunteers with Taxotere 1 for 1 h Figure 7 In¯uence of Taxol 1 and its constituents paclitaxel and cremophor-EL on the RBC morphology. Increasing concentrations of Taxol 1 (A), paclitaxel (B), and cremophor-EL (C) were incubated with whole blood (haematocrit 45%) for 60 min at 378C, and RBC morphology, expressed as morphological index, was assessed by light microscopy. n=6. *P50.05 and **P50.001 compared to control.
Figure 8 In¯uence of Taxotere
1 and tween 80 on RBC morphology. Increasing concentrations of Taxotere 1 (A) and tween 80 (B) were incubated with whole blood (haematocrit 45%) for 60 min at 378C, and RBC morphology, expressed as morphological index, was assessed by light microscopy. n=6. *P50.001 compared to corresponding control.
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Taxanes and blood rheology M. Mark et aldose-dependently increased whole blood viscosity both at high and low shear rate, but did not change plasma viscosity. At the highest dose examined (resulting in a concentration of 100 mM docetaxel) the increase of whole blood viscosity was 19% at high and 50% at low shear rate, respectively. The formulation vehicle of Taxotere 1 , namely tween 80, caused a dose-dependent increase of whole blood viscosity at both shear rates as well as of plasma viscosity ( Figure 5 ). The highest concentration assessed (5%) increased blood viscosity at high shear rate by 59%, at low shear rate by 71%, and plasma viscosity by 18%.
A dose-dependent stomatocytic shape transformation was observed, which is illustrated in Figure 6 . Profound stomatocytosis was found with either 100 mM Taxol 1 or Taxotere 1 ( Figure 6A ,C), which was also seen with the formulation vehicle of Taxotere 1 , tween 80 ( Figure 6D ), but not with pure paclitaxel ( Figure 6B ). The quanti®cation of these shape changes with the help of the morphological index is shown in Figures 7 and 8 . Taxol 1 dose-dependently decreased the morphological index (indicating dose-dependent stomatocytic shape transformation; Figure 7A ), which was not seen with pure paclitaxel ( Figure 7B ). The formulation vehicle cremophor-EL had a stomatogenic potential ( Figure 7C ) although to a lesser degree than expected from Taxol 1 ( Figure 7A) . A dose-dependent decrease in the morphological index was also seen with Taxotere 1 (Figure 8A ) and by a similar extent with the vehicle of Taxotere 1 , tween 80 ( Figure 8B ). As shown in Figure 9 , both the Taxol 1 -induced changes in whole blood viscosity and stomatocytic shape transformation were time-dependent. It was almost not seen after 2 min, but obvious after 60 min. These changes were not, or at the most only partially reversible, which is also shown in Figure 9 . When RBCs were washed three times in phosphate-buered saline and then resuspended in autologous plasma, blood viscosity at high shear rate and the degree of stomatocytosis remained unaected, whereas blood viscosity at low shear rate signi®cantly decreased towards the control level.
Because of these in vitro observations we searched for similar ®ndings in seven patients undergoing chemotherapies containing Taxol
1
. Characteristics of these patients are shown in Table 1 . As shown in Figure 10 , whole blood viscosity (adjusted haematocrit 45% by removal of autologous plasma) at 94.5 s 71 was signi®cantly increased from 5.09+0.30 to 5.44+0.38 mPa.s (P=0.031) after Taxol 1 -infusion; individual data are shown in Figure 10A . Low shear viscosity remained unaected (9.73+0.99 and 10.29+0.99 mPa.s; P=0.249; Figure 10B ). These values are lower than those observed in the in vitro experiments, which may be due to plasma dilution by the hydration performed before Taxol 1 -infusion. As shown in Figure 10C , there was a tendency of plasma viscosity to increase (from 1.24+0.05 to 1.34+0.08 mPa.s; P=0.059). RBC morphology showed a signi®cant stomatocytic shape transformation (decrease of the morphological index from 0.02+0.26 to 70.42+0.35; P=0.004; Figure 10D ). Scanning electron micrographs of a RBC of patient 4 before and after administration of Taxol 1 are shown in Figure 6E ,F, respectively.
Discussion
The main ®ndings of the present study are that commercial taxane drug formulations induce a stomatocytic shape transformation of RBCs and increase blood viscosity in vitro and also in vivo. Since blood samples were directly drawn prior to (i.e. after the administration of premedications) and following the application of Taxol 1 alone, possible eects of other drugs were eliminated as confounders. Haematocrits were all adjusted to 45% to exclude in¯uences of changing haematocrits on the results. Our in vitro experiments further identify the formulation vehicles cremophor-EL and tween 80, respectively, as most important inducers of these eects. -induced eects on viscosity and RBC morphology and missing reversibility after wash-out. Taxol 1 (corresponding to 100 mM paclitaxel) was incubated with whole blood (haematocrit 45%) at 378C, and whole blood viscosity at high (A) and low (B) shear rate as well as RBC morphology (C), were determined at two consecutive time points (2 min and 60 min). Afterwards, RBCs were washed with PBS, resuspended in autologous plasma, and measurements were repeated at 378C. n=6. *P=0.01 and **P=0.001 compared to control.
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Taxanes and blood rheology M. Mark et alAccording to the bilayer couple theory (Sheetz & Singer, 1976 ) a stomatocytic shape transformation occurs when a compound is preferentially intercalated into the inner hemilea¯et of the membrane lipid bilayer, leading to a relative expansion of the inner hemilea¯et and hence of the membrane towards the cell interior. Taxol 1 induced stomatocytosis dose-dependently but paclitaxel alone without the formulation vehicle cremophor-EL had no in¯uence on RBC shape. Since cremophor-EL used alone induced less stomatocytosis than expected from the Taxol 1 data (Figure  7) , one must assume a synergy of the taxane and the formulation vehicle in intercalating into the inner hemilea¯et of the RBC membrane and inducing stomatocytosis. This seems conceivable since cremophor-EL acts as a solubilizer and may increase the tendency of paclitaxel to interact with the lipid bilayer. Alternatively, the other drug contained in Taxol   1 , ethanol, may also play a role. Some alcohols may accumulate in the inner hemilea¯et of the RBC membrane and induce stomatocytosis (Chabanel et al., 1985) . It is noteworthy that cremophor-EL is also used as a formulation vehicle for other drugs, e.g. cyclosporine, which has been found to induce stomatocytosis (Reinhart, 1993) . Taxotere 1 induced a stomatocytic shape transformation to an even stronger degree than Taxol
1
. This was paralleled by the ability of the vehicle tween 80 to induce signi®cant stomatocytosis at concentrations at which cremophor-EL failed to in¯uence RBC shape.
It is interesting that the RBC shape change and the impairment of blood viscosity was not reversible upon removal of Taxol 1 in vitro. This is in contrast to the reversibility of the echinocytosis induced by the cytostatic drug 5-¯uorouracil (Baerlocher et al., 1997) or the stomatocytosis induced by ifosfamide (Reinhart et al., 1999) . This indicates that commercial taxane drug formulations have a higher anity for the RBC membrane.
In agreement with earlier observations stomatocytosis had a profound eect on blood rheology (Reinhart et al., 1992; 1999; Meiselman, 1978) . The increase in whole blood viscosity at high shear rate, which is representative of¯ow conditions in arteries, arterioles, and non-venous portions of the microcirculation (Chien, 1975) , is due to decreased RBC deformability induced by the stomatocytic shape transformation. Whole blood viscosity at low shear rate is primarily determined by RBC aggregation and is relevant for blood ow in veins and under stasis (Chien, 1975) . Stomatocytes, also called cup-shaped RBCs, have a greater propensity to stack one in another and hereby form RBC aggregates (Reinhart et al., 1989) , which explains the earlier observation of increased rouleaux formation under Taxol 1 (Shimomura et al., 1998) . We did not observe any signi®cant eect of Taxol 1 on low shear blood viscosity when administered in patients.
It is conceivable that the stomatocytic shape transformation and increase in blood viscosity induced by commercial taxane drug formulations may be a contributing pathophysiologic mechanism behind the various cardiovascular side eects of taxanes (Rowinsky & Donehower, 1995; Arbuck et al., 1993; Rowinsky et al., 1991; Hekmat, 1996; Roth et al., 1993) and cremophor-EL (Besarab et al., 1987; Bowers et al., 1991) . The clinical signi®cance, however, remains speculative. As most cancer patients have anaemia, their low haematocrits could compensate for the decreased RBC deformability and prevent an increase in whole blood viscosity. As the formulation vehicles seem to account for most of the in¯uence on blood rheology, other galenic forms might be desirable. In this context it is noteworthy that a new taxane analogue, which needs three times less polyoxyethylated castor oil as a vehicle, is currently in clinical trials (Hidalgo et al., 2001) . Various cytostatic drugs have a high anity for cell membranes and hence aect cell Figure 10 Changes of viscosity and the RBC morphology in patients undergoing Taxol 1 -based chemotherapies. Blood was drawn from patients directly prior to and after administration of Taxol 1 , for details see Table 1 . Whole blood viscosity (haematocrit 45%) at high (A) and low (B) shear rate, plasma viscosity (C), and the RBC morphological index (D) were measured. n=7. P=0.031 for high shear viscosity; P=0.249 for low shear viscosity; P=0.059 for plasma viscosity; P=0.004 for morphological index (paired t-test).
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Taxanes and blood rheology M. Mark et alshape. Vinblastine (Jacobs et al., 1972) , ifosfamide (Reinhart et al., 1999) , and taxanes induce stomatocytosis, 5-¯uoro-uracil (Baerlocher et al., 1997) and mesna (Reinhart et al., 1999) echinocytosis. Stomatocytic agents counterbalance echinocytic agents and vice versa (Alhanaty & Sheetz, 1981; Reinhart & Chien, 1987) . Certain drug combinations may, therefore, be equilibrative with regard to the interaction with cell membranes, not only of RBCs but of cells in general (e.g. endothelial cells), while other combinations may have additional or even potentiating eects.
